SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934




        Date of Report (Date of Earliest Event Reported) April 22, 2002



                              Cross Country, Inc.
--------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)




Delaware                          0-33169                             13-4066229
--------------------------------------------------------------------------------
(State or Other                 (Commission                     (I.R.S. Employer
Jurisdiction of                 File Number)                      Identification
incorporation)                                                              No.)





       6551 Park of Commerce Blvd., N.W., Suite 200, Boca Raton, FL 33487
--------------------------------------------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)





                                 (561) 998-2232
              (Registrant's Telephone Number, Including Area Code)



                                 Not Applicable
--------------------------------------------------------------------------------
         (Former Name or Former Address, If Changed Since Last Report.)




<PAGE>



ITEM 5.  OTHER EVENTS.

         Incorporated  by reference is a press release  issued by the Company on
April 22, 2002, which is attached hereto as Exhibit 1.1.




ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

(c)  EXHIBITS.

Exhibit  Description

1.1      Press release issued by the Company on April 22, 2002


                                       2


<PAGE>



                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                            CROSS COUNTRY, INC.




                                            BY:   /s/ Emil Hensel
                                                 ---------------------- 
                                                 Name: Emil Hensel
                                                 Title:  Chief Financial Officer



Date:  April 22, 2002


                                       3


<PAGE>



Exhibit 1.1

CROSS COUNTRY, INC. ANNOUNCES TERMINATION OF LOCKUP ON 635,107 SHARES.



     BOCA RATON,  Fla., April 22, 2002/ -- Cross Country,  Inc.  (Nasdaq:  CCRN)
today  announced that an aggregate of 635,107 shares of common stock will become
eligible  for resale in the public  market on April 23,  2002 as a result of the
termination of the underwriters' lockup in connection with the Company's initial
public offering effected on October 24, 2001.

     In connection with the Company's  public offering  effected March 20, 2002,
Cross  Country,  its directors and  executive  officers as well as  Charterhouse
Equity  Partners III, L.P. and Morgan Stanley  Private Equity agreed not to sell
or transfer  any shares of common  stock until June 19, 2002 without the consent
of the  underwriters.  Accordingly,  on such  date an  aggregate  of  11,977,464
restricted  shares  will become  eligible  for resale in the public  market.  In
addition,  in connection with such offering,  DB Capital  Investors L.P. and the
Northwestern  Mutual Life  Insurance  Company agreed not to sell or transfer any
shares  of common  stock  held by them  until May 20,  2002.  On such  date,  an
aggregate of 635,587 shares of common stock will become eligible for sale in the
public market.

      The  underwriters  may  release  some  or all of  these  shares  from  the
restrictions  at  any  time.  Cross  Country,  Inc.  is a  leading  provider  of
healthcare  staffing  services in the United  States.  The company has an active
client  base  of  over  3,000  hospitals,  pharmaceutical  companies  and  other
healthcare providers across all 50 states.

                                      ####

Contact: Brian Hekman, Director, Corporate Communications 800-998-5187